2‐(fluorine‐18)fluoro‐2‐deoxy‐D‐glucose positron emission tomography in the detection and staging of malignant lymphoma

The authors undertook a prospective evaluation of the clinical value of 2‐fluoro [18‐]‐2‐deoxyglucose positron emission tomography (FDG‐PET) in the detection and staging of malignant lymphoma compared with computed tomography (CT) and bone marrow biopsy (BMB).

[1]  W. Finn,et al.  New classifications for non-Hodgkin's lymphoma. , 1999, Cancer treatment and research.

[2]  R. Castellino,et al.  Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease. , 1984, AJR. American journal of roentgenology.

[3]  M. Orringer,et al.  Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. , 1988, Radiology.

[4]  R. Coleman,et al.  The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma , 1998, Cancer.

[5]  P. Parikh,et al.  A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non‐hodgkin's lymphoma , 1998, Cancer.

[6]  M Schwaiger,et al.  Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. , 1998, Blood.

[7]  B. Gross,et al.  Upper abdominal lymph nodes: criteria for normal size determined with CT. , 1991, Radiology.

[8]  R. Fisher,et al.  Staging of non-Hodgkin's lymphoma. , 1980, Seminars in oncology.

[9]  W. Chilcote,et al.  Abdominal lymphadenopathy: spectrum of CT findings. , 1991, Radiographics : a review publication of the Radiological Society of North America, Inc.

[10]  M. Shipp.  Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease? , 1994, Blood.

[11]  W. Payne,et al.  Malignant lymphoma of the spleen. A review of 49 cases in which the diagnosis was made at splenectomy , 1966, Cancer.

[12]  N. Nissen,et al.  The liver in Hodgkin's disease--II. Histopathologic findings. , 1982, European journal of cancer & clinical oncology.

[13]  E. Noordijk,et al.  Treatment, patterns of failure, and survival of patients with Stage I nodal and extranodal non‐Hodgkin's lymphomas, according to data in the population‐based registry of the comprehensive cancer centre west , 1998, Cancer.

[14]  E. Fishman,et al.  CT of lymphoma: spectrum of disease. , 1991, Radiographics.

[15]  J. D. van der Walt,et al.  Detection of lymphoma in bone marrow by whole-body positron emission tomography. , 1998, Blood.

[16]  A. Buck,et al.  F-18-FDG-PET zur Primärdiagnostik und Dignitätsbeurteilung pleuraler Prozesse , 1999, Nuklearmedizin.

[17]  R. Castellino.  Imaging techniques for staging abdominal Hodgkin's disease. , 1982, Cancer treatment reports.

[18]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[19]  H. Golomb,et al.  The staging of non-Hodgkin's lymphomas. , 1990, Seminars in oncology.

[20]  R. Munker,et al.  Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases , 1995, Cancer.

[21]  H. Schirrmeister,et al.  Positron emission tomography for detection and staging of malignant lymphoma. , 2000, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[22]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[23]  A. Skarin,et al.  Non-Hodgkin's lymphoma. , 1989, Advances in internal medicine.

[24]  J Kotzerke,et al.  Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. , 1997, Radiology.

[25]  J Kotzerke,et al.  Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  J. Quetz,et al.  [B-image sonography in lymph node staging of the head and neck area. A comparison with palpation, computerized and magnetic resonance tomography]. , 1991, HNO.

[27]  A. Santoro,et al.  Magnetic resonance imaging in the initial staging of Hodgkin's disease and non-Hodgkin lymphoma. , 1991, European journal of radiology.

[28]  M E Phelps,et al.  Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  R. Castellino.  Diagnostic imaging studies in patients with newly diagnosed Hodgkin's disease. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  A. Shields,et al.  The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  E. Staab,et al.  Lymphoma of the solid abdominal viscera. , 1990, Radiologic clinics of North America.

[32]  Tsuneo Matsumoto,et al.  Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes. , 1995, Thorax.

[33]  F. Joly,et al.  Late complications after Hodgkin's disease. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  W Hiddemann,et al.  Lymphoma classification--the gap between biology and clinical management is closing. , 1996, Blood.

[35]  J. Roodenburg,et al.  Detection of unknown occult primary tumors using positron emission tomography , 1998, Cancer.

[36]  P. Valk,et al.  Analytical decision model for the cost-effective management of solitary pulmonary nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Castellino Ra.  Imaging techniques for staging abdominal Hodgkin's disease. , 1982 .

[38]  R. Hoppe.  Hodgkin's disease: complications of therapy and excess mortality. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[39]  T. Miller,et al.  Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A southwest oncology group study , 1990, Cancer.

[40]  S. Reske,et al.  Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma , 1999, European Journal of Nuclear Medicine.

[41]  E. Merkle,et al.  Extranodal malignant lymphoma: detection with FDG PET versus CT. , 1998, Radiology.

[42]  S. Reske,et al.  18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  B. Coiffier,et al.  A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte. , 1998, Cancer.